| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Division of Tumor Immunology, Sidney Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts 02115
A sensitive radioimmunoassay for 5-fluorodeoxyuridine (FdUrd) and 5-fluoro-2'-deoxyuridine 5'-monophosphate has been developed by using antibody induced in rabbits, [3H]FdUrd, and a separation technique with nitrocellulose filters. Antibody specificity was characterized by using compounds chemically related to FdUrd and comparing their effectiveness for displacing [3H]FdUrd from the antibody-combining site. Drug levels in serum samples from patients receiving FdUrd chemotherapy were easily and rapidly determined, and the serum disappearance of the drug was followed by this method. FdUrd was also detected and quantified in urine samples. According to the antiserum used, as little as 1 to 10 pmol FdUrd were measurable.
1 This work was supported in part by NIH Grant CA 19589.
2 To whom requests for reprints should be addressed, at Division of Tumor Immunology, Sidney Farber Cancer Institute, Harvard Medical School, 44 Binney Street, Boston, Mass. 02115.
Received 8/31/77. Accepted 3/30/78.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |